Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
10,373,101
-
Total 13F shares
-
1,485,110
-
Share change
-
-2,034,513
-
Total reported value
-
$3,460,093
-
Price per share
-
$2.34
-
Number of holders
-
42
-
Value change
-
-$33,750,758
-
Number of buys
-
23
-
Number of sells
-
26
Institutional Holders of CervoMed Inc. - Common Stock, $0.001 par value (CRVO) as of Q4 2024
As of 31 Dec 2024 CervoMed Inc. - Common Stock, $0.001 par value (CRVO) had 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,485,110 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Woodline Partners LP, Perigon Wealth Management, LLC, NORTHERN TRUST CORP, MORGAN STANLEY, UBS Group AG, and Nuveen Asset Management, LLC.
This table shows 43 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.